Effects of methoxsalen on the metabolism of acetaminophen in humans.
We reported recently that the drug methoxsalen, a potent suicide inhibitor of hepatic cytochrome P-450, decreases the metabolic activation of acetaminophen and prevents its hepatotoxicity in mice. We have now studied the effects of methoxsalen on the metabolism of acetaminophen in humans. In vitro, 100 microM methoxsalen decreased by 40% the covalent binding of a [3H]acetaminophen metabolite to microsomal proteins after incubation of [3H]acetaminophen with human liver microsomes and an NADPH-generating system. In vivo, a single oral dose of methoxsalen (30 mg), given 3 hr before acetaminophen (1 g), decreased by 38% the partial apparent oral salivary clearance of acetaminophen into glutathione-derived conjugates (the end products of its oxidative metabolism) in nine human volunteers. These observations demonstrate that methoxsalen decreases the metabolic activation of acetaminophen in humans.
D000082:Acetaminophen / Q000378:metabolism*; D001711:Biotransformation / Q000187:drug effects; D065607:Cytochrome P-450 Enzyme Inhibitors; D006801:Humans; D008730:Methoxsalen / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000187:drug effects* / Q000378:metabolism; D012463:Saliva / Q000032:analysis; D014556:Urine / Q000032:analysis
D065607:Cytochrome P-450 Enzyme Inhibitors; D000082:Acetaminophen; D008730:Methoxsalen